RGLS logo

Regulus Therapeutics (RGLS) Long Term Debt

Annual Long Term Debt

$1.05 M
-$713.00 K-40.33%

December 31, 2023


Summary


Performance

RGLS Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Quarterly Long Term Debt

$476.00 K
-$199.00 K-29.48%

September 30, 2024


Summary


Performance

RGLS Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

RGLS Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-40.3%-29.5%
3 y3 years+100.0%-90.3%
5 y5 years--

RGLS Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-85.1%at low-93.3%at low
5 y5-year-85.1%-100.0%-93.3%-100.0%
alltimeall time-94.7%-100.0%-97.6%-100.0%

Regulus Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$476.00 K(-29.5%)
Jun 2024
-
$675.00 K(-22.2%)
Mar 2024
-
$868.00 K(-17.7%)
Dec 2023
$1.05 M(-40.3%)
$1.05 M(-14.9%)
Sep 2023
-
$1.24 M(-12.7%)
Jun 2023
-
$1.42 M(-11.1%)
Mar 2023
-
$1.60 M(-9.6%)
Dec 2022
$1.77 M(-75.1%)
$1.77 M(-8.7%)
Sep 2022
-
$1.94 M(-60.5%)
Jun 2022
-
$4.90 M(-16.3%)
Mar 2022
-
$5.85 M(-17.5%)
Dec 2021
$7.09 M(>+9900.0%)
$7.09 M(+175.9%)
Sep 2021
-
$2.57 M(-5.5%)
Jun 2021
-
$2.72 M(-5.1%)
Mar 2021
-
$2.87 M(>+9900.0%)
Dec 2020
$0.00
$0.00(-100.0%)
DateAnnualQuarterly
Sep 2017
-
$19.84 M(+0.1%)
Jun 2017
-
$19.83 M(+0.1%)
Mar 2017
-
$19.82 M(+0.1%)
Dec 2016
$19.80 M(+75.6%)
$19.80 M(+0.1%)
Sep 2016
-
$19.79 M(+0.0%)
Jun 2016
-
$19.79 M(+85.5%)
Sep 2014
-
$10.66 M(-14.3%)
Jun 2014
-
$12.45 M(-7.1%)
Mar 2014
-
$13.40 M(+18.8%)
Dec 2013
$11.28 M(+11.3%)
$11.28 M(-19.0%)
Sep 2013
-
$13.92 M(-4.6%)
Jun 2013
-
$14.59 M(+22.7%)
Mar 2013
-
$11.89 M(+17.4%)
Dec 2012
$10.13 M(+1.3%)
$10.13 M(-41.9%)
Sep 2012
-
$17.44 M(+4315.9%)
Jun 2012
-
$395.00 K(-96.0%)
Dec 2011
$10.00 M
$10.00 M

FAQ

  • What is Regulus Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Regulus Therapeutics?
  • What is Regulus Therapeutics annual long term debt year-on-year change?
  • What is Regulus Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly long term debt year-on-year change?

What is Regulus Therapeutics annual long term debt?

The current annual long term debt of RGLS is $1.05 M

What is the all time high annual long term debt for Regulus Therapeutics?

Regulus Therapeutics all-time high annual long term debt is $19.80 M

What is Regulus Therapeutics annual long term debt year-on-year change?

Over the past year, RGLS annual long term debt has changed by -$713.00 K (-40.33%)

What is Regulus Therapeutics quarterly long term debt?

The current quarterly long term debt of RGLS is $476.00 K

What is the all time high quarterly long term debt for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly long term debt is $19.84 M

What is Regulus Therapeutics quarterly long term debt year-on-year change?

Over the past year, RGLS quarterly long term debt has changed by -$199.00 K (-29.48%)